MARKET

TBIO

TBIO

Telesis Bio
NASDAQ
0.3152
+0.0062
+2.01%
After Hours: 0.3153 +0.0001 +0.03% 18:08 04/22 EDT
OPEN
0.2997
PREV CLOSE
0.3090
HIGH
0.3338
LOW
0.2997
VOLUME
70.35K
TURNOVER
0
52 WEEK HIGH
3.010
52 WEEK LOW
0.2997
MARKET CAP
9.49M
P/E (TTM)
-0.1919
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at TBIO last week (0415-0419)?
Weekly Report · 21h ago
Telesis Bio announces leadership transition amid new commercial focus
Seeking Alpha · 4d ago
Telesis Bio Inc. Announces Strategic Focus On Game-Changing Gibson Sola Enzymatic DNA Synthesis Platform And BioXp mRNA Solutions; Todd R. Nelson To Step Down As CEO, Eric Esser, President And COO Of Telesis Bio, Will Assume The Role Of The Co's CEP, Effective Immediately
Telesis Bio Inc. Is a leader in automated benchtop DNA and mRNA synthesis solutions. The company's Gibson SOLA platform can deliver on-demand synthesis in 1 – 2 days. Telesis Bio will focus its efforts on the BioXp automation platform on mRNA synthesis workflows. Todd Nelson, the company's CEO, will no longer be the CEO of the company.
Benzinga · 4d ago
Telesis Bio Leadership Shake-Up and Board Expansion
TipRanks · 4d ago
TELESIS BIO INC - ON APRIL 16 BOARD APPROVED EXPANSION OF BOARD FROM SEVEN TO EIGHT MEMBERS
Reuters · 4d ago
TELESIS BIO INC - ERIC ESSER, PRESIDENT AND COO OF TELESIS BIO, WILL ASSUME ROLE OF COMPANY'S CEO AND WILL JOIN COMPANY'S BOARD
Reuters · 4d ago
Weekly Report: what happened at TBIO last week (0408-0412)?
Weekly Report · 04/15 09:23
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Marin Software (NASDAQ:MRIN) stock is rocketing more than 67% after upgrading its integration with Microsoft Advertising. Shareholder meetings, clinical updates, an annual report and delisting plans are moving stocks this morning. The biggest pre-market stock movers on Wednesday morning are Marin Software and iCoreConnect.
Investorplace · 04/10 11:28
More
About TBIO
Telesis Bio Inc. is a provider of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) solutions. The Company provides automated multi-omic and synthetic biology solutions focused on providing applications to enable researchers to rapidly and reproducibly build or write high-quality synthetic DNA and messenger Ribonucleic Acid (mRNA) and short oligonucleotides that are ready to use in many downstream synthetic biology enabled markets. Its BioXp system consolidates, automates, and optimizes the entire synthesis, cloning and amplification workflow. Its on-market and its planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, Benchtop reagents and Custom Gibson Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS) solutions. BioXp Select kits offer customers the ability to use non-Telesis Bio DNA while using the BioXp system to perform synthetic biology workflow applications.

Webull offers Telesis Bio Inc stock information, including NASDAQ: TBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TBIO stock methods without spending real money on the virtual paper trading platform.